Immunomedics Inc
(IMMU)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2004 | 12-2003 | 09-2003 | 06-2003 | 03-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,530 | -10,041 | -5,183 | N/A | -4,217 |
| Depreciation Amortization | 1,614 | 1,151 | 579 | N/A | 1,206 |
| Other Working Capital | 916 | 1,341 | 810 | N/A | -7,187 |
| Other Operating Activity | -17 | -23 | 37 | 0 | 411 |
| Operating Cash Flow | $-13,016 | $-7,572 | $-3,757 | $N/A | $-9,787 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,271 | 3,421 | 18 | N/A | 14,423 |
| PPE Investments | -884 | -548 | -211 | N/A | -6,330 |
| Investing Cash Flow | $4,387 | $2,873 | $-193 | $N/A | $8,093 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -956 | -638 | -319 | N/A | N/A |
| Common Stock Issued | 43 | 9 | 9 | N/A | 1 |
| Financing Cash Flow | $9,087 | $-629 | $-310 | $N/A | $1 |
| Beginning Cash Position | 13,602 | 13,602 | 13,602 | N/A | 13,063 |
| End Cash Position | 14,059 | 8,274 | 9,342 | N/A | 11,371 |
| Net Cash Flow | $457 | $-5,328 | $-4,260 | $N/A | $-1,692 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,016 | -7,572 | -3,757 | N/A | -9,787 |
| Capital Expenditure | -884 | -548 | -211 | N/A | -6,330 |
| Free Cash Flow | -13,900 | -8,120 | -3,968 | 0 | -16,117 |